Significance of neurotrophic factors in major depression;Die bedeutung neurotropher faktoren für die depression und ihre therapie

Nervenheilkunde

Volumn 21, Issue 10, 2002, Pages 497-501

  Hinze Selch, D ^a   Koch, J M ^a   Aldenhoff, J B ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Antidepressant; CREB; Cytokine; Depression; Neurotrophin

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; MARKER; NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR;

BLOOD CELL; DEPRESSION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NONHUMAN; PREDICTION; PROTEIN INTERACTION; REVIEW;

EID: 0036924050     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ. Journey from cachexia to obesity by TNF. FASEB J 1997; 11: 743-51.
2. Becker G, Berg D, Lesch KP, Becker T Basal limbic system alteration in major depression: A hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol 2001; 4: 21-31.
3. Butterweck V, Winterhoff H, Herkenham M. St John's wort, hypericin, and imipramine: A comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats. Mol Psychiatry 2001; 6: 547-64.
4. Casaccia-Bonnefil P, Gu C, Chao MV. Neurotrophins in cell survival/death decisions. Adv Exp Med Biol 1999; 468: 275-82.
5. Chesnokova V, Melmed S. Minireview: Neuroimmuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gpl30 signaling molecules. Endocrinology 2002; 143: 1571-4.
6. Dechant G. Molecular interactions between neurotrophin receptors. Cell Tissue Res 2001; 305: 229-38.
7. De Kloet ER, Oitzl MS, Schobitz B. Cytokines and the brain corticosteroid receptor balance: Relevance to pathophysiology of neuroendocrine-immune communication. Psychoneuroendocrinology 1994; 19: 121-34.
8. Drevets WC. Functional neuroimaging studies of depression: The anatomy of melancholia. Annu Rev Med 1998; 49: 341-61.
9. Dryden S, Brown M, King P, Williams G. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine. Horm Metab Res 1999; 31: 353-6.
10. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular hypothesis of depression. Arch Gen Psychiatry 1997; 54: 597-606.
11. Etienne-Manneville S, Chaverot N, Strosberg AD, Couraud PO. ICAM-1-coupled signalling pathways in astrocytes converge to cyclic AMP response element bind protein phosphorylation and TNF-alpha secretion. I Immunol 1999; 163: 668-74.
12. Havel PJ. Peripheral signals conveying metabolic information to the brain: Short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001; 226: 963-77.
13. Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M, Pollmächer T. Effects of antidepressants on weight and on the plasma levels of leptin, TNF-a and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 2000; 23: 13-9.
14. Holsboer E The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23: 477-501.
15. Johnson RW. The concept of sickness behavior: A brief chronological account of four key discoveries. Vet Immunol Immunopathol 2002; 87: 443-50.
16. Koch JM, Kell S, Aldenhoff JB. Differential effects of fluoxetine and imipramine on the phosphorylation of the transcription factor CREB and cell-viability. J Psychiatr Res (in Druck).
17. Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB. Changes in CREB phosphorylation during recovery from major depression. J Psychiatr Res (in Druck).
18. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmächer T. Body weight, the tumor necrosis factor system and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry (in Druck).
19. Lanquillion S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370-9.
20. Manier DH, Shelton RC, Sulser F. Noradrenergic antidepressants: Does chronic treatment increase or decrease nuclear CREB-P? J Neural Transm 2002; 109: 91-9.
21. Marz P, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 1999; 26: 191-200.
22. Mullington JM, Hinze-Selch D, Pollmacher T. Mediators of inflammation and their interaction with sleep: Relevance for chronic fatigue syndrome and related conditions. Ann NY Acad Sci 2001; 933: 201-10.
23. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25.
24. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-47.
25. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16: 2365-72.
26. Pollmächer T, Schuld A, Kraus T, Haack M, Hinze-Selch D, Mullington J. Schlaf und schläfrigkeit im rahmen von infektionen und im rahmen experimenteller immunmodulation beim Menschen. Somnologie 2000; 4: 68-78.
27. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445-52.
28. Russo-Neustadt A, Beard RC, Cotman CW. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 1999; 21: 679-82.
29. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-35.
30. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull 2001; 55: 625-9.
31. Sutcliffe JG, de Lecea L. The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000; 62: 161-8.
32. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: Different circuits, different purposes. Physiol Behav 2001; 74: 683-701.
33. Zetterstrom TS, Pei Q, Madhav TR, Coppell AL, Lewis L, Grahame-Smith DG. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropsychopharmacology 1999; 38: 1063-73.